search
Back to results

Phase 1: Randomized Evaluation of a System to Deliver Mobile Cognitive Behavioral Therapy (P1RESPECT)

Primary Purpose

Pain, Postoperative, Analgesics, Opioid

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
InCaveo's EOA system with integrated mobile CBT
Sponsored by
InCaveo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pain, Postoperative focused on measuring pain

Eligibility Criteria

55 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patient has a Pain Catastrophizing Score >16
  2. 55 years of age and older.
  3. English speaking.
  4. Has a smartphone (iPhone).
  5. Able to swallow oral medications.
  6. No continuous daily opioid as defined as more than 15 days in the 30 days before surgery.
  7. Undergoing TKR surgery.
  8. Patients who are willing and able to comply with scheduled visits and study procedures.

Exclusion Criteria:

  1. Diagnosed with Opioid Use Disorder (OUD).
  2. Actively using illicit drugs.
  3. Allergy to opioids
  4. Older than 85 years

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    InCaveo EOA System

    Control Group-usual care with pill bottles

    Arm Description

    InCaveo EOA System (including integrated CBT but without tapering) group

    UCPB group-usual care with pill bottles

    Outcomes

    Primary Outcome Measures

    Pain Catastrophizing Scale (PCS)
    A measure of the extent of catastrophizing

    Secondary Outcome Measures

    Full Information

    First Posted
    April 5, 2021
    Last Updated
    April 5, 2021
    Sponsor
    InCaveo
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04836169
    Brief Title
    Phase 1: Randomized Evaluation of a System to Deliver Mobile Cognitive Behavioral Therapy
    Acronym
    P1RESPECT
    Official Title
    Phase 1: Randomized Evaluation of a System to Deliver Mobile Cognitive Behavioral Therapy to Lower Pain Catastrophizing Scores
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2021
    Overall Recruitment Status
    Unknown status
    Study Start Date
    October 2021 (Anticipated)
    Primary Completion Date
    April 2022 (Anticipated)
    Study Completion Date
    May 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    InCaveo

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    Yes
    Device Product Not Approved or Cleared by U.S. FDA
    Yes
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The clinical study described in this Clinical Investigation Plan (CIP) will be completed in two stages, Phase I and Phase II. The results of Phase I will confirm patient use of InCaveo's EOA system with integrated mobile CBT but without tapering to improve The Pain Catastrophizing Scale (PCS) scores, and secondarily scores on the VNS pain scale, the Tampa Scale of Kinesiophobia (TSK), and patient satisfaction scores in the subacute period (defined as 2 weeks to 3 months post TKR). Statistically significant positive results on the Pain Catastrophizing Scale (PCS) will trigger phase 2. Phase 1 will also inform the detailed conditions and patient management algorithms for Phase II.
    Detailed Description
    The InCaveo End Opioid Addiction (EOA) System is an integrated pain management therapeutic and opioid tapering system providing alternate treatment options via self-service Cognitive Behavior Therapy (CBT) built into a mobile software app, patient medication usage, and tracking of patient PROs. It is designed to be used alongside Usual Standard of Care using Pill Bottles or to simplify, Usual Care with Pill Bottles (UCPB) treatment practices. The InCaveo EOA System is designed to improve a set of patient outcome measures, primarily Pain Catastrophizing Scale (PCS) and secondarily the Visual Numeric Pain (VNS), Kinesiophobia (TSK) and satisfaction scores while facilitating the ability of patients to taper off their pain medication faster than through the use of USPB in the management of post-operative pain. In order to reduce confounding variables, the study will focus on pain management following a single surgical procedure: Total Knee Replacement (TKR) surgery.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pain, Postoperative, Analgesics, Opioid
    Keywords
    pain

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Randomized parallel-group
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    30 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    InCaveo EOA System
    Arm Type
    Experimental
    Arm Description
    InCaveo EOA System (including integrated CBT but without tapering) group
    Arm Title
    Control Group-usual care with pill bottles
    Arm Type
    No Intervention
    Arm Description
    UCPB group-usual care with pill bottles
    Intervention Type
    Device
    Intervention Name(s)
    InCaveo's EOA system with integrated mobile CBT
    Intervention Description
    integrated pain management therapeutic and tapering system including a software apt that manages and tracks patient-reported outcomes, including pain levels, medication use, quality of life
    Primary Outcome Measure Information:
    Title
    Pain Catastrophizing Scale (PCS)
    Description
    A measure of the extent of catastrophizing
    Time Frame
    60 days

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    55 Years
    Maximum Age & Unit of Time
    85 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patient has a Pain Catastrophizing Score >16 55 years of age and older. English speaking. Has a smartphone (iPhone). Able to swallow oral medications. No continuous daily opioid as defined as more than 15 days in the 30 days before surgery. Undergoing TKR surgery. Patients who are willing and able to comply with scheduled visits and study procedures. Exclusion Criteria: Diagnosed with Opioid Use Disorder (OUD). Actively using illicit drugs. Allergy to opioids Older than 85 years
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Cynthia Harris, BS
    Phone
    8326776747
    Email
    cindy@clinregconsult.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Michael A Daniel, MBA
    Phone
    4154070223
    Email
    madaniel@clinregconsult.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Hoyman Hong, MD
    Organizational Affiliation
    InCaveo
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Phase 1: Randomized Evaluation of a System to Deliver Mobile Cognitive Behavioral Therapy

    We'll reach out to this number within 24 hrs